Melatonin Stada

Melatonin, the active ingredient in Melatonin Stada, is a melatonin receptor agonist presented as a tablet for oral use. It is used to help regulate the sleep‑wake cycle and promote sleep onset in adults with sleep disorders. GNH USA supplies Melatonin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Stada acts on the melatonin MT1 and MT2 receptors to support circadian rhythm regulation and is indicated for several sleep‑related conditions.

Insomnia: reduces sleep onset latency and improves sleep continuity. Jet lag: assists in adjusting the internal clock after rapid time‑zone travel. Shift‑work disorder: helps align sleep timing for individuals working non‑standard hours.

Melatonin Stada may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness during daytime - Headache - Dizziness - Nausea - Vivid dreams or nightmares - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or swelling - Severe dizziness or fainting - Mood changes including depression or anxiety - Hormonal effects like menstrual irregularities

When considering Melatonin Stada, several safety measures should be observed.

Avoid use in children without medical supervision: pediatric safety has not been established. Consult a physician if you have a history of depression or seizure disorders: melatonin may influence mood or neuronal excitability. Do not combine with sedative medications without professional guidance: additive sleepiness may occur. Limit use during pregnancy or breastfeeding until advised by a healthcare provider: safety data are limited. Store below 25°C: keep in the original pack, protect from moisture.

Melatonin can interact with other agents that influence the central nervous system or hormonal pathways.

Major Interactions (Avoid): - Central nervous system depressants (e.g., benzodiazepines, barbiturates): may cause excessive sedation. - Anticoagulants (e.g., warfarin): melatonin may enhance anticoagulant effect. - Immunosuppressants (e.g., cyclosporine): potential alteration of drug metabolism.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs, MAO inhibitors): may affect serotonin levels. - Oral contraceptives: possible reduction in contraceptive efficacy. - Caffeine-containing products: may counteract melatonin’s sleep‑promoting action.